WINTON GROUP Ltd - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 113 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$2,324,000
-34.8%
43,990
-24.4%
0.08%
-17.4%
Q2 2020$3,564,000
+151.7%
58,153
+132.4%
0.09%
+148.6%
Q1 2020$1,416,000
-5.9%
25,025
-5.3%
0.04%
+76.2%
Q4 2019$1,505,000
-18.1%
26,427
-23.0%
0.02%
-4.5%
Q3 2019$1,837,000
+323.3%
34,317
+372.2%
0.02%
+175.0%
Q2 2019$434,0007,2670.01%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders